New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine Essay

Exclusively available on IvyPanda Available only on IvyPanda
Updated: Mar 7th, 2024

Introduction

This enterprise project plan is for setting up an on-demand delivery business for medicine. The business idea was conceived from the backdrop of the failure of existing healthcare plans to effectively meet the needs of underserved populations. Key considerations discussed in the document include the legal ramifications of setting up the enterprise, its value proposition, and design features. Empirical data was obtained from business operators serving low-income neighborhoods in the UK and secondary data retrieved from published sources. The views of the respondents were collected using the questionnaire survey method and examined using the Statistical Packages for the Social Sciences (SPSS). An online business platform is proposed as the differentiating factor for the new business plan.

We will write a custom essay on your topic a custom Essay on New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine
808 writers online

The findings of this investigation address convenience, safety, and affordability as the main considerations for the proposed business plan. The main value proposition posed by startup is the reduction of inequality in the sale and distribution of medicine. It is projected that the business will thrive by automating processes associated with medicine delivery. The business plan will be implemented on a virtual model where customers can simply order for drugs via their mobile phones and have them delivered expeditiously. Therefore, it is expected that the on-demand pharmacy will increase access to quality medicine among underserved populations.

Problem Framing

Traditionally, most people have obtained their goods and services from brick-and-mortar stores. However, in the last decade, the global business environment has experienced significant changes caused by political, social, and economic fluctuations in society (Lee, 2020). Some key drivers for this change are the spread of internet services, increased geopolitical instability across nations, and COVID-19 (Mehta, Saxena and Purohit, 2020). Particularly, the COVID-19 pandemic has been the biggest driver of change in the global business environment. These change agents have highlighted the need for businesses to innovate to remain relevant (Lee, 2020). Similarly, they have pushed businesses to automate their processes to adapt to the pressures that arise from exposure to market uncertainties.

Multinational organizations have led their peers in adopting automation by augmenting some of their core activities with digital platforms. Some entrepreneurs have seen the opportunity created by this change and chosen to start new enterprises within the e-commerce space (Kampf, 2018; Mehta, Saxena and Purohit, 2020). This trend thrives within a broader desire for innovators to optimize market opportunities, while avoiding uncertainties of the global environment.

Organizations that have successfully transitioned from the brick-and-mortar business model to a virtual one have benefitted from increased resiliency in the wake of widespread market uncertainties. Most of them have reported increased efficiency of automating their processes because machines are more reliable to complete operational tasks compared to human beings (Ditrich and Sassenberg, 2017). Some entrepreneurs argue that automation has helped them to reduce their overall costs by eliminating the need to rely on people to complete tasks (Shin, Park and Kim, 2021). Furthermore, unlike human beings, machines can work for a long time without getting tired or needing replacement.

Despite the promise of an improved business environment from automation, socioeconomic inequalities have persisted. These inequalities exist due to various reasons, some of which are policy-related and others products of the lack of innovation or creativity (Polhemus et al., 2019). For example, the recent COVID-19 pandemic proved that systemic inequality exists among societies and affect people’s quality of life in various ways (Kamiike, 2020). For example, residents of low-income neighborhoods have not benefitted from automated healthcare service delivery because of existing socioeconomic inequalities at various levels of care (Okoro et al., 2020). Thus, they have been excluded from accessing quality healthcare services.

In the UK, the percentage of people who are unable to access quality healthcare services is relatively lower than most countries. However, supplementary healthcare services are not available to all people that need them (Alonzo, Popescu and Zubaroglu, 2022). Likewise, they largely depend on one’s ability to marshal resources that would enable them to get the best services (Lazic and Williams, 2020). Due to these disparities, some people have not benefitted from automated health care systems (Jose, 2020). Some of them are uninsured, while others do not have their details captured in existing databases (Bhaduri, 2018). This problem partly arises from the failure of entrepreneurs to understand how to use the benefits of technological advancements to improve people’s welfare. Consequently, few people have exploited existing opportunities to use automation to solve current problems affecting society.

1 hour!
The minimum time our certified writers need to deliver a 100% original paper

The online delivery of goods and services is an emerging area of new business development. It can be used to address glaring inequalities in access to goods and services across different demographic groups in the community (Varma and Dutta, 2022). Particularly, it creates an opportunity to address gaps in the delivery of medicine to underserved populations (UK Office for National Statistics, 2021). This potential exists because gaps in the delivery of medical services have magnified existing inequalities that have traditionally affected how people relate with one another (Sarkees, Fitzgerald and Lamberton, 2021). These problems are detrimental to the sustainability of civilized societies (du Plessis, 2022). Thus, there is an opportunity for entrepreneurs to mitigate societal problems by developing new business ideas.

Subject to unique demographic and market-related factors affecting new enterprise development, there is scanty information regarding the best business strategies to use to exploit virtual market opportunities. Particularly, there is a gap in the literature, which fails to capture information that business owners can use to develop strategies for the pharmaceutical industry. The current study recognizes the opportunity that automation of healthcare services offers to the low-end segment of the drug market. This business segment is associated with low capital requirements of setting up a business, geographical delimitation of outreach programs, and the ability to manage large volumes of data (Doherty, 2019; Eze, Chinedu-Eze and Awa, 2021). The findings of the present investigation will aid in the development of an enterprise management project aimed at setting up an on-demand business that delivers medicine to low-income dwellers in the UK.

Market Analysis

This section of the enterprise plan evaluates the current state of the literature that are relevant to the proposed business idea. Key sections of the investigation explore trends in the pharmaceutical market that anchor the enterprise plan, gaps in the market to be filled, and a market analysis of the business environment. The aim is to highlight the role that the new firm will play in improving access to pharmaceutical products in the low-end segment of the healthcare industry. These details are included in the current review because of their potential to influence the operations of the proposed business idea.

Macro-environmental Factors

New business start-ups are subject to changing market dynamics that directly or indirectly affect market operations. In this section of the review, the external market environment of the proposed business plan will be examined using PESTLE and Porter’s Five-Force frameworks.

PESTLE Analysis

The PESTLE model includes five areas of analysis to analyze a business’s external environment – political, economic, social, technological, legal, and environmental (Dhanora, Sharma and Park, 2021). Details relating to each tenet of the external market analysis plan are discussed below.

Political: Poor access to goods and services in low-income communities has been a problem for local governments and policymakers alike. For a long time, this issue has not been addressed because of the failure to prioritize the needs of low-income populations at policy and operational levels (Assefa, 2021). Thus, the entrepreneurial spirit among underserved people has remained unlocked. This situation has made it difficult to initiate change and eliminate inequalities in the healthcare sector (Ertel, 2021). To this end, current initiatives aimed at minimizing socioeconomic inequalities among different income groups have been ineffectively implemented (UK Office for National Statistics, 2021). These imbalances have morphed into unequal allocation of resources in affluent and low-income neighborhoods.

Economic: A business’s economic environment affects consumer purchasing power and the sustainability of new product development processes. Rising healthcare costs and global uncertainties have created unfavorable economic conditions that undermine the ability of healthcare service providers to offer affordable services (Pashley, Ozieranski and Mulinari, 2022; García-Canal et al., 2018). These influences affect the quality of healthcare services in low-income neighborhoods when underserved populations buy low quality pharmaceutical products because they cannot afford the desired medicine.

Remember! This is just a sample
You can get your custom paper by one of our expert writers

Despite the dampening economic outlook in many countries, the sales numbers of pharmaceutical products have increased over the years. In the UK, this trend is affirmed with Figure 2.1 below showing that the sharpest hike in pharmaceutical expenditure occurred in 2020 at the height of the COVID-19 pandemic (Statista, 2022).

 Pharmaceutical trends in the UK 
Figure 2.1: Pharmaceutical trends in the UK

It is estimated that UK consumers spend about £12 billion annually on pharmaceutical expenses (Statista, 2022). Broadly, since 2012, the trend has demonstrated a year-on-year increase in the amount of money consumers spend on pharmaceutical products (Dhanora, Sharma and Park, 2021). These findings suggest that pharmaceutical sales are resilient in an uncertain economy. The increase in demand for pharmaceutical products during the COVID-19 lockdown period also demonstrates the buoyancy of the industry during adversity (Varma and Dutta, 2022). Despite the risk that sales numbers could decline in a post-COVID period, healthcare services remain important to the sustenance of life.

Social: Countries are moving to adopt universal health coverage as a social welfare doctrine. This push has the potential to transform the healthcare sector by eliminating out-of-pocket expenses and replacing them with insured payment plans (Pashley, Ozieranski and Mulinari, 2022). The widespread adoption of the universal health doctrine has the potential to make healthcare services more accessible and affordable to all (Kamiike, 2020). Challenges brought by the COVID-19 pandemic have accelerated the need for countries to adopt a universal healthcare policy (Barshikar, 2020). Indeed, the COVID-19 pandemic has demonstrated that brick-and-mortar stores can be closed at any time. Therefore, the desire to become financially free from health expenses inspires some of the changes aimed at adopting a universal health coverage policy.

Dwindling prospects of achieving universal health coverage heightens concerns about the welfare of low-income populations. Most of them lack adequate food and supplies of essential products, such as medicine (Newman, Obschonka and Block, 2022). At the same time, their dwellings lack proper infrastructure, skills, and income to gain access to quality goods and services (Gates et al., 2019). Indeed, as affluent and middle-income dwellers simply order their goods online, low-income residents cannot access similar services because of poor access to reliable digital infrastructure to address their unique needs (Okoro, Hillman and Cernasev, 2020). Subject to these disparities, the proposed business idea strives to minimize these market gaps by offering alternative services in the area of pharmaceutical products delivery. Residents of low-income neighborhood are likely to benefit from this plan because they have poor access to essential commodities.

Technological: Like many economic sectors, the healthcare industry has been traditionally dependent on the brick-and-mortar business model to reach its target market (Xie, 2021). This model requires patients to present themselves physically to a hospital setting to receive healthcare services and buy medicine (Sarkees, Fitzgerald and Lamberton, 2021). However, technology has changed how these agents access healthcare services with some of the biggest changes reported in the delivery of medicine services through telemedicine and mobile communication technologies (Williamson, 2018). In this context of service delivery, the adoption of advanced technological tools in healthcare service delivery highlights the complexity of the pharmaceutical environment today.

The integration of new technological tools in the healthcare service sector has created significant changes in consumer behavior. However, the original intention was to converge healthcare delivery services and activities to the virtual space. Telemedicine and automation are some byproducts of these developments (Barshikar, 2020). Coupled with the effects of the COVID-19 pandemic on the pharmaceutical industry, the adoption of new technologies in the sector has increased interest in online medical sales (Li et al., 2021). In 2020 alone, it was estimated that up to 10% of all total healthcare sales were completed online (Proprietary Association of Great Britain, 2022). Brick-and-mortar businesses have reported dramatic differences in their online sales records because positive changes of up to a 73% increase in revenue have been reported (Proprietary Association of Great Britain, 2022). The trend is expected to continue with more investments in the sector anticipated after the COVID-19 pandemic ends.

The adoption of technology in the healthcare industry has created changes in consumer purchasing intentions. This development has influenced the quantity of products customers are willing to buy (Banal-Estañol, Newham and Seldeslachts, 2021). For example, the transition of healthcare sales to the online space has promoted the idea of an “all-in-one” sales platform where customers buy goods in bulk to avoid going out of the house frequently (Proprietary Association of Great Britain, 2022). Observers consider these developments to be detrimental to the survival of conventional brick-and-mortar business models (Proprietary Association of Great Britain, 2022). Indeed, today, customers may require a clear and valid reason to make a physical visit to the pharmacy.

Legal: The healthcare sector is among the most regulated industries in the world. Restrictions imposed on the industry are due to its sensitivity to the sustenance of human life (Sparkmon, 2020). Therefore, most restrictions are geared towards promoting patient safety (Banal-Estañol, Newham and Seldeslachts, 2021). To this end, authorities have outlined policies that regulate drug distribution and supply (Proprietary Association of Great Britain, 2022). Of major concern to the current probe is a stipulation in the UK law that over-the-counter medicines should be sold only when a patient presents a prescription from a doctor (Proprietary Association of Great Britain, 2022). The proposed idea for the new business provides an opportunity for patients to bypass this policy by avoiding physical verification before purchasing drugs. To ensure that the new business complies with existing drug laws, customers will be required to present a digital copy of the prescription before the completion of a sale.

We will write
a custom essay
specifically for you
Get your first paper with
15% OFF

Environmental: Excessive consumption produces massive amounts of waste to the environment. Research studies suggest that more than 100,000 tons of pharmaceutical products are consumed daily around the world (European Environmental Bureau, 2018). This vast quantity of waste has heightened concerns about the impact of the pharmaceutical industry on the environment (European Environmental Bureau, 2018). For example, the release of hazardous waste products into the environment via rivers and streams has been a top concern for environmentalists (Banal-Estañol, Newham and Seldeslachts, 2021). They are concerned that improper waste disposal of drugs and medical products could be injurious to people and the environment (Banal-Estañol, Newham and Seldeslachts, 2021). At the same time, attention has been drawn to the disposal of antibiotic waste into the environment (European Environmental Bureau, 2018). Broadly, these issues suggest that the environmental impact of the pharmaceutical industry is a key tenet of its overall performance. Table 3.1 below summarizes the findings of the PESTLE analysis above.

Table 3.1: PESTLE analysis

FactorDescription
PoliticalPoor attention to low-income neighborhoods
EconomicLow-income populations are neglected
Uncertain global market
Rising healthcare costs
SocialShift towards universal health insurance coverage
Competing healthcare and economic interests
TechnologicalChanges in consumer intentions
Automation
EnvironmentalHazardous waste

Porter’s Five Force Analysis

Researchers have used Porter’s Five Force model to analyze elements in a company’s external environment that are likely to influence its business success. This practice justifies the use of the analytical tool to examine environmental factors that are likely to affect the performance of new business start-ups (Banal-Estañol, Newham and Seldeslachts, 2021). Consistent with the nature of Porter’s key tenets of the five-force model, the subsequent analysis will evaluate UK’s pharmaceutical market based on five key areas of review – threat of substitute products, consumer purchasing power, supplier bargaining power, influence of rivals, and ease of market entry.

Threat of New Entrants (Low): The pharmaceutical industry is dominated by major drug producers, such as GlaxoSmithKline (GSK), Pfizer, and Merck (Proprietary Association of Great Britain, 2022). The sensitivity of medical products to human health and the vigor of tests associated with product development decrease the probability that new entrants would have a significant impact on the market. This is why name brands perform better than new ones in this industry (Proprietary Association of Great Britain, 2022). Analysts attribute the difference in performance to varied levels of trust that people have towards traditional and private-label brands (Sparkmon, 2020). Overall, these variances have lowered the threat of new entrants in the sector.

Rivalry among Existing Competitors (High): The lucrative nature of the pharmaceutical industry has created fierce rivalry among manufacturers. These players compete on several fronts, including new product development, price cuts, corporate influence, and advertising space, just to mention a few (Xie, 2021). Research studies suggest that markets with intense competitive rivalries are often associated with a low potential for growth (Xie, 2021). Comparatively, those with high growth rates are likely to diffuse the tension among rivals. Subject to this environment, since 2010, the UK pharmaceutical market has reported an increase in the number of players. As of 2022, more than 500 pharmaceutical companies were operating in the UK (Pashley, Ozieranski and Mulinari, 2022). Figure 2.2 below shows that the number of pharmaceutical companies in the UK has steadily increased over the years.

Number of Pharmaceutical industries in the UK
Figure 2.2: Number of Pharmaceutical industries in the UK

Based on the sheer number of pharmaceutical industries in the UK, it can be assumed that there is intense rivalry in the market. This environment leaves little room for entrepreneurs to replicate existing business models. Furthermore, some scholars believe that there is a low growth potential of the pharmaceutical industry in the UK (Gatersleben et al., 2019). Therefore, it is believed that the increased numbers of competitors operating in the market are competing for a small share of the industry. Thus, it could be deduced that there is intense rivalry among competitors in the pharmaceutical industry.

Threat of Substitute Products (High): There is a high threat of substitute products in the pharmaceutical industry due to the availability of generic drugs in multiple product categories. Generic drugs work in the same manner as original drugs do, except that they are cheaper and more affordable (Bhaduri, 2018). Therefore, most pharmaceutical companies with mainstream brands encounter competition from generic brand manufacturers. The only exception to this rule is the purchase of novel products, which do not have a generic version yet (Bhaduri, 2018). In such cases, customers are forced to buy original products. Nonetheless, novel products accounts for a small share of the market, meaning that they cannot negate the threat of substitute products in the pharmaceutical industry.

Customer Bargaining Power (Medium): Customer bargaining power refers to the influence that consumers have in influencing the decision of pharmaceutical companies when developing or marketing their products. This force has a moderate impact on the pharmaceutical industry. On one hand, the modern consumer has access to adequate information about his/her health, which enables them to demand for better quality products and services (Martin et al., 2017). Indeed, customers today are more aware of the impact of medicine on their health more than older generations (Proprietary Association of Great Britain, 2022). This increased level of self-awareness could be attributed to the proliferation of new technologies through smartphones and computers (Lee et al., 2019). They have made it possible for people to access health data easily. On the other hand, customers equally have little or no influence on the kind of decision made by pharmaceutical industries. Thus, it could be assumed that customer bargaining power in the pharmaceutical sector is moderate.

Supplier Bargaining Power (Low): The supplier bargaining power in the pharmaceutical industry is low due to the overreliance on several organic chemicals for production. Indeed, the manufacturing chain is broad to the extent that it can undermine the power that any one significant supplier would have in the market (Sarkees, Fitzgerald and Lamberton, 2021). This low supplier bargaining power explains why most players have been unable to influence the price of medicine through negotiation (Alzougool, 2018). At the same time, the low supplier power has made it possible for companies to embrace forward integration as part of their growth strategies (Sarkees, Fitzgerald and Lamberton, 2021). This plan involves the acquisition of suppliers into a business’ ownership structure and a company’s production processes. The increased entrenchment of this practice in the healthcare sector explains why the supplier bargaining power remains low. Table 3.2 below summarizes findings of the Porters’ five-force analysis.

Table 3.2: Porter’s five-force analysis

FactorLevel
Threat of New EntrantsLow
Competitive RivalryHigh
Threat of Substitute ProductsHigh
Supplier Bargaining PowerLow
Consumer Bargaining PowerModerate

Industry Trends and Disruptions

The delivery of medicine to people’s homes, as a business idea, has captured the attention of investors around the world. Many of them are supporting the idea with the hope that they may exploit lucrative opportunities that exist therein (Alonzo, Popescu and Zubaroglu, 2022). Relative to this observation, there is a general trend towards the integration of technology in various aspects of healthcare practice. In lieu of this development, the support for e-commerce adoption has permeated different facets of the pharmaceutical industry, including drug administration and treatment.

Telemedicine and the automation of patients’ records are some of the ways through which service providers have integrated new technology in their organizational plans. The pharmaceutical industry, which is a subgroup of the larger healthcare industry, has also taken the cue and adopted automation as a core part of their core business processes and activities (Li, Dostie and Simard-Duplain, 2022). Concisely, some healthcare institutions have developed a catalogue of prescription medicine for groups of patients (Cheng et al., 2020). For example, diabetes management is mostly carried out by healthcare service providers using automated systems (Harris et al., 2021). Drug management services are equally experiencing a similar level of transformation because healthcare service providers are increasingly acknowledging the benefits of automation (Sexton, Nguyen and Roberts, 2021). Thus, increased efficiency at various levels of operation has been reported.

Sector Regulation and Legislation

The rules and regulations governing business operations are often influenced by the laws and policies of a country. The UK has strict laws governing the sale and distribution of medicine (Morelato et al., 2020). Particularly, there are stringent regulations governing the sale and distribution of “prescription medicine.” Consequently, it is imperative that the proposed business is compliant with existing legal provisions surrounding the sale of drugs (Cheng et al., 2020). Subsequent sections of this study will discuss how the expectation of compliance will be achieved.

Insights and Key Findings from Business Owners

In this section of the paper, the findings obtained from the secondary and primary data analysis processes are assessed and reviewed. To recap, primary data was obtained from business persons operating pharmacies in low income communities in the UK. Alternatively, secondary data was gathered from books, journals, and credible websites. The importance of using the two sets of data in the probe was to create a basis for comparing and contrasting qualitative and quantitative findings for better comprehension and analysis of the market. This process led the researcher to identify areas of convergence and disparity regarding the proposed business plan. The findings of the primary data section are highlighted below.

Insights

The researcher completed an ethical approval form stipulating the terms of engagement with the respondents. Appendix 16 contains information regarding the investigation type and the ethical responses given by the researcher in this area of assessment. The format for this review is based on the research onion framework, as explained by Seuring et al. (2022). It suggests that five frameworks of analysis should be discussed when exploring techniques adopted by researchers in collecting data from respondents (Wagner, Kawulich and Garner, 2019). The six levels include research philosophy, approach to theory development, design, method, time analysis, and techniques, which include data collection and analysis procedures.

Based on the desire to collect relevant market data, the pragmatism approach was adopted as the suitable research philosophy for the current probe. Alternatively, given the dual response to theory development linked with this investigation, the deductive techniques was selected as the preferred research approach (Lê and Schmid, 2022). In terms of research methodology, a combination of both qualitative and quantitative techniques was adopted in the study to provide holistic data (Bailey et al., 2019). The justification for using both techniques is rooted in the exploratory nature of the proposed business idea. The time framework for analyzing market data was based on the cross-sectional time series approach, which captures views of the target audience at once (da Silva Frost and Ledgerwood, 2020). In terms of strategy development, the researcher employed the survey technique as the preferred model for obtaining market data.

Surveys were administered online to business owners in three low-income neighborhoods in the UK. The researcher accessed them using the snowball sampling technique. It works when one person who has agreed to participate in a study introduces a researcher to a new one (Köhler, Smith and Bhakoo, 2019). In the current probe, the researcher used an initial contact to gain access to several business owners who knew one another and operated in the same market. The informants completed a survey questionnaire that took about 30 minutes to review.

The surveys were categorized into two sections. The first part of the questionnaire captured the respondents’ demographic and business characteristics. This part of the analysis included a review of the respondents’ marital status and age. These variables were included in the analysis because scholars argue that people’s age and marital status affects business decisions and market opinions (Abreu-Afonso et al., 2022). Thus, it was critical to include these variables in the review to investigate whether they impacted the respondents’ views on the research topic. Information about the businesses plan was similarly included in the survey because business profiles and experiences have an impact on the success of a new enterprise (De Mooij, 2019). Three variables relating to the business plan that were sampled in the study included the number of years business owners managed their enterprises and the number of branches they operated. It was assumed that businesses which have more outlets and have been in operation for a long period would provide more reliable data about the proposed enterprise management project.

The second part of the survey questionnaire was the factor analysis section. It sampled the views of the informants regarding the best financing, pricing, advertisement, and prescription validation models to use in the startup. Each of the independent areas of probe mentioned in the questionnaire was assigned four statements to make a list of 20 questions that were posed to the informants (see appendix 1). It is assumed that the list of questions was comprehensive enough to cover the scope of research topic. Alternatively, the researcher obtained supplementary information from secondary data sources, including books and journals, published within the last five years. The goal was to use secondary data to contextualize primary information obtained from the informants. Both sets of primary and secondary data sources provided adequate details about the external market dynamics and internal business competencies of the proposed business plan that could be used to increase its odds of success.

For the data analysis part, the researcher used the Statistical Packages for the Social Sciences (SPSS) software to review the respondents’ views. The descriptive and inferential analysis techniques, which are associated with the SPSS software, were primarily used for data analysis. The research questions were answered after obtaining information about the suitability of adopting a digital marketing strategy and the delivery of miscellaneous goods as key tenets of the proposed business plan.

As highlighted above, all the pieces of information gathered in the probe helped to identify the best marketing and product development strategies to use in the proposed business plan. Comparatively, the difficulty in scheduling a standardized time for conducting the surveys emerged as a challenge to the data collection process. This problem occurred because of the wide geographical dispersion of the respondents and their different daily schedules. Therefore, there was a need to transfer the data collection process online to accommodate these variations. This strategy enabled the researcher to develop a snapshot view of the business environment. It helped the researcher to get a representative sample of the views of business owners about how to improve the proposed market entry strategies. The data was later used to create homogenous strategies for enterprise management.

Key Findings

Demographic Findings

This research study sampled the views of 62 respondents, who worked in the UK pharmaceutical industry. The descriptive analysis part of the data analysis process involved capturing their demographic characteristics – age, marital status, type of business ownership, number of business outlets, and years in business operation. The respondents’ marital statuses were included in the review because of the impact that one’s family setting has on their decision-making process. For example, according to Abreu-Afonso et al. (2022), married people tend to be “less aggressive” in business compared to single people. Similarly, widowed informants are likely to receive less support in business financing compared to married partners (Xian, Jiang and McAdam, 2021). The same logic is true in predicting the financial assistance they receive to start a business or run it. Based on these findings, the informants were requested to state their marital statuses. Appendix 2 shows the distribution of the respondents according to this variable. It shows that most of the respondents were either single or married. Those who were divorced or widowed formed the smallest sample of the population.

Age

The second demographic variable in the study was age and according to Appendix 3, most of the respondents (37.1%) were young people between 18 and 25 years. The high number of younger business owners in the study was surprising because the researcher assumed that the entrepreneurs would be older.

Type of Business Ownership

The concept of business ownership was included in the present study to know more about the nature of the respondents’ firms. Appendix 4 outlines the distribution of the sampled cases based on business ownership structures. The findings demonstrate that most of the firms sampled were partnerships and sole proprietorships. These structures could explain the type of ownership models adopted in low-income neighborhoods in the UK.

Number of Business Outlets

The justification for analyzing the number of business outlets managed by the respondents was to assess the respondents’ knowledge of the market. The findings depicted in Appendix 5 reveal that most of the informants operated pharmacies that had less than three outlets. This finding means that their knowledge of the business could be limited to their areas of operation.

Years in Business Operation

The last demographic variable sampled in the investigation related to the number of years in operation. According to Appendix 6, most of the businesses visited were operational for less than a year. Those that existed for more than ten years formed the smallest sample of enterprises. Similarly, the findings depicted in Appendix 6 reveal that most of the respondents (51.6%) had less than two years work experience – signifying a limited understanding of the market.

Analysis of Variables

VariableDescriptionResults
1Financing OptionsThe descriptive analysis part of this study covered the main variables of the study, which were financing options, pricing strategy, procedures for verifying prescription, and value addition practices. The findings depicted in Appendix 7 show that most of the respondents preferred to use personal financing methods to start a business. This outcome was affirmed because none of the mean values for the variable reached the value 2.
2Pricing StrategyThe findings depicted in Appendix 8 shows that a low-cost pricing plan would work well in a low-income community setting. This pricing plan is consistent with the low income level of the inhabitants.
3Verification of PrescriptionsThe findings highlighted in Appendix 9 affirmed the importance of seeking prescriptions before fulfilling an order. This statement was evident because few respondents disagreed with the importance of verification prescriptions. The outcome is affirmed by the low mean value – less than 3 – of the responses.
4Value AdditionThe findings highlighted in Appendix 10 demonstrate that most of the respondents “agreed” with the view that an on-demand pharmaceutical business would be embraced in the market because it adds value to the community. This statement was based on the low mean score (less than 3) that the participants had towards this variable. Stated differently, they “agreed” with the statements made.

Inferential Analysis

The second part of the questionnaire sampled the informants’ views about five areas of business operation, including value addition services, financing model, product promotion, pricing, and prescription verification modalities. These areas of business development were included in the study after analyzing data about small business development in the pharmaceutical industry (Cotter et al., 2021). Prescription medication was included in the review, as a research variable, because of the need to verify a doctor’s prescription before dispatching medicine to customers. The same argument was used to determine the best financing, pricing, promotion, and value addition plans for the new enterprise project.

Impact of Marital Status on Findings

As highlighted in this study, a person’s marital status has an impact on their decision-making processes. This effect is notably true in entrepreneurship where it is believed that variations in marital status affect the zeal in which people implement their business strategies (Xian, Jiang and McAdam, 2021). To this end, it was important to undertake a comparative analysis of the findings to establish whether the marital status of the informants influenced their responses. The impact of the respondents’ marital status on their views was investigated using the one-way ANOVA method.

According to Appendix 11, one statement out of the 20 posed to the respondents met the significance threshold of p>0.05. This finding suggests that the marital status of the respondents did not affect the quality of their responses. This finding contradicts those of other researchers who have argued that one’s family structure impacts their decision-making processes (Miller, Wiklund and Yu, 2020). Nonetheless, the low impact of the informant’s marital status on the findings means that their views were independent of their family settings or social structures. This finding promotes objectivity in the interpretation of the results.

Impact of Age on Findings

It was important to understand the impact of the respondents’ age on the findings to establish whether their views were biased towards people of a specific demographic group. This analysis was critical to the probe because age is a moderating variable in business relationships and strategy development (Xian, Jiang and McAdam, 2021). Appendix 12 summarizes findings that were obtained from this assessment. They reflect those of the impact of marital status on the respondents’ views because the statements posed to the respondents did not meet the significance threshold of p>0.05. This finding means that the respondent’s ages did not influence their views on the findings. Again, this outcome promotes the idea that the views presented by the business owners reflected an objective assessment of strategies that would be relevant to the establishment of a new enterprise plan. Thus, the insights provided by the informants about the research topic were devoid of age-related influences.

Impact of Number of Branches on Findings

The third variable investigated in the present study related to the number of outlets that the business owners operated in their respective markets and its influence on the views expressed by the respondents. This review was important to the study because it was assumed that business owners operating multiple enterprises would be more knowledgeable about strategies that are likely to work in the market compared to those who operated fewer stores. Appendix 13 shows the findings of the one-way ANOVA method. The probe meant to investigate if the number of outlets run by the informants affected their views on the research topic.

As highlighted in Appendix 13, the number of outlets operated by the respondents did not affect their views on the research topic. This is because none of the statements posed by them met the significance threshold of p>0.05, which would have implied that the number of outlets operated affected the quality of responses. This finding is inconsistent with research studies, which suggest that the business experiences of entrepreneurs who are running multiple firms enriches their experiences and outlook of the market (Morelato et al., 2020). Thus, it could be deduced that the quality of responses given by the informants was devoid of this influence.

Impact of Ownership Structure on Findings

The impact of ownership structure on the findings presented in this study formed the basis for the current probe. It was intended to establish whether differences in the ownership structures of the informants affected their opinions. This analysis was critical to the present probe because researchers opine that the ownership structure of a business influences the kind of strategies they adopt or implement in the market (Morris, 2022). The contents of Appendix 14 summarize the findings associated with this aspect of the review. Its contents reveal that business ownership structures did not affect the quality of responses given by the researcher. This statement stems from the insignificant number of statements that met the threshold of p>0.05. Thus, it could be assumed that the informants’ views were independent of the kind of firms they managed. This finding is inconsistent with those of other researchers who opined that business ownership structures affected the strategic approaches employed in the market.

Impact of Years of Operation on Findings

The last part of the inferential analysis related to an investigation of the impact of years of operation on the findings presented by the respondents. This aspect of the review was important to the probe because it is assumed that business owners with more experience in the market are likely to have a better understanding of the current market dynamics compared to those who have been in the market for fewer years (Hansford, Thomas and Wyatt, 2022). Consequently, it was important for the researcher to investigate if the years of business operations had an impact on the findings given by the informants.

The findings depicted in Appendix 15 are similar to those generated by other demographic variables examined in this study. Notably, none of the statements posed to the informants met the significance threshold of p>0.05. This finding means that the business experiences of the informants did not influence their views on the research topic. This finding contradicts those of other researchers who argue that business experience has an impact on the quality of strategy development employed by business owners (Banal-Estañol, Newham and Seldeslachts, 2021). Consequently, it can be deduced that experience did not play a significant role in influencing the views of the respondents regarding the questions posed to them.

During the process of validating the findings, 43 of the business owners sampled in this study indicated that they would implement the proposed business idea as an appendage to their existing business models. Five of them admitted that the proposed business idea was superior to their current enterprise models, while the rest showed no interest in the proposed business idea. The reasons for this disparity in responses provide grounds for future research.

Competition Analysis

In this section of the probe, a competitive analysis of the UK pharmaceutical industry was undertaken to understand players that operate in the market and their possible impact on the proposed business idea. To this end, three areas of competitive analysis are discussed and they include defining the existing solutions to the problem, benchmarking of competitive products, and documenting the lessons learned from competitors. Collectively, these three areas of review will help to understand the competitive landscape of the market and explain how the proposed business could be designed to navigate the obstacles and optimize existing opportunities.

Existing Solutions to the Problem

As highlighted in this study, low-income consumers in the UK pharmaceutical market are underserved. This situation is caused by several factors, among them being low levels of insurance and number of healthcare facilities in low-income neighborhoods (Zu and Krever, 2020). Currently, pharmacies have a home delivery service where customers can request for products or services to be delivered at their doorstep. This approach to service delivery has worked for a long time and recently been buoyed by COVID-19 lockdowns (Sarkees, Fitzgerald and Lamberton, 2021). However, this solution is limited to the extent of the kind of products that can be delivered to customers.

The only products available for home delivery are those that do not need a prescription. This limitation excludes most pharmaceutical products that customers need, thereby forcing them to make physical visits to pharmacies to obtain these drugs (Pringsheim et al., 2017). The proposed business strives to address this problem by expanding the range of products that can be ordered and delivered to customers. In other words, the business delivery strategy is not designed to be limited by prescription barriers because there is an integrated verification model that addresses this problem.

Competitive Product Benchmarking

Product benchmarking is important in business management to familiarize entrepreneurs with trends in the marketplace that may impact sales and service delivery. The delivery of pharmaceutical products at home is a relatively new type of business with few players in the market. Some of the most dominant actors in the UK pharmaceutical industry include Netmed and NowRx, which operate as smartphone applications that allow people to order for medicine online and have them delivered at their doorstep (Netmed Inc., 2022; NowRx Inc., 2022). However, unlike the current proposal to set up a similar business in the UK, Netmed does not exclusively focus on the low-end market (Netmed Inc., 2022). However, the unique feature about this business is its interactive nature.

Netmed operates in a similar fashion as Amazon does, where medicine can be picked from online shelves, put on a cart and payments made before delivery. The digital interface of the business is highly interactive, thereby creating room for customers to engage with the company (Netmed Inc., 2022). Therefore, it offers valuable lessons that could be assimilated into the current business plan. The same logic applies to NowRx, which operates in the UK industry through proprietary application software (NowRx Inc., 2022). NowRx is unique from other players in the market because it offers free delivery services. Stated differently, it charges customers for the products purchased but not for their delivery.

The delivery of medicine for free is a unique feature of NowRx because other players in the market charge for this service. Thus, it would be useful to understand how the company manages to do so and remain competitive in the marketplace. A brief investgation into the operations of this business reveals that the firm works with other pharmacies to include its proprietary software in their businesses (NowRx Inc., 2022). Therefore, its operations are augmented with the traditional brick-and-mortar business model. This plan significantly reduces it cost of operation and efficiency of services. A similar strategy could be adopted in the proposed business plan. Partnerships could be created with existing business owners to offer home-delivery services as an additional feature of the current model of operation.

Besides the two pharmaceutical companies highlighted above, product benchmarking for the proposed business plan will be based on the activities of companies that engage in the delivery of grocery products in the UK. For example, in terms of time, groceries are often ordered by customers and delivered within two hours. This schedule is relevant to the proposed business plan because it indicates the average time that customers can be promised to have their goods delivered. Similarly, as evidenced in the grocery delivery business operated by Co-op Delivery (2022), customers will be required to state their postal codes to facilitate the delivery of products to their homes. These pieces of information will be required during the order delivery phase.

The main point of difference between the proposed product benchmarking plan and the proposed enterprise idea is the kind of products sold and the regulations surrounding them. Given that medicine is the preferred product to be sold in the proposed business plan, customers will be required to upload scanned copies of their prescriptions to an online portal for verification before product delivery commences, as recommended by Chopra, Avhad and Jaju (2021). Therefore, the product benchmarking criteria for the proposed business will include a post-code requirement and a fixed estimate of delivery time. An additional feature will be the scanned prescription requirement which will form part of the order placement process.

Lessons Learned from Competition

An analysis of the competitive landscape of the proposed business plan offers invaluable lessons that can be adopted in the startup. The main issue learned from this analysis is the kind of products to stock. The competitive analysis has shown that competitors often partner with brick-and-mortar businesses to implement their strategies. Therefore, this integrative format will be largely adopted in the proposed business idea to support its operations.

Value Proposition

The proposed business idea seeks to add value to the lives of consumers living in underserved areas of the UK. To this end, it is important to underscore the main value proposition that will be offered in the market. Particularly, attention is paid to the personalities of the target market, pain points, and value preposition formulas that can be adopted. They are discussed below.

Personas

Table 6.1 below summarizes the characteristics of the target market, using a patient named James Brown as an example.

Name: James Brown

Demographic CharacteristicsGoalsMotivationBiography
Age: 34
Work: Salonist
Gender : Male
Location: Manchester, UK
Home Country: China
  1. Take care of ailing mother
  2. Save more money
  3. Find quality and affordable medicine
Fear (20%)
Greed (35%)
Social Support (45%)
James is a 34-year old driver who is taking care of his ailing mother. He is looking for a second job to increase his earnings and pay for the mother’s hospital bills
PersonalityFrustrationsBrandsPreferred Sales Channels
Openness – 40%

Conscientiousness – 30%

Agreeableness – 30%

  • Cash
  • Strained family relationships
BrandsBrick-and-mortar –
20% preferenceAutomated systems –
80% preference

As highlighted in this business plan, the target market is low-income customers. In this section of the review, the consumer profile of this demographic group is assessed to understand how it aligns with the proposed business plan. To create a consistency of purpose, Maslow’s hierarchy of needs theory will be used to evaluate the needs and requirements of the target market. By employing its principles, it is possible to know how to address varying customer needs using proven marketing strategies. Consistent with this plan of action, the theory emerges as a useful framework for reviewing consumer purchasing intentions.

As its name suggests, the Maslow hierarchy of needs theory stemmed from its author, Abraham Maslow. He demonstrated that consumer purchasing behaviors are motivated by different layers of needs that primarily drive human reasoning and actions (Shoib et al., 2022). According to the theory, these layers of needs are categorized into five sections, which include physiological, safety, love/belonging, self-esteem, and self-actualization needs (Yu, 2022). The proposed business plan taps into safety needs. Thus, it could be assumed that the value proposition of providing on-demand medicine meets a basic human need – healthcare. This level of need is commensurate with other similar desires that people have, including security and freedom from fear.

Consumer needs and market requirements often vary with the level of want associated with human desire. Low-income populations often experience challenges relating to their quest to fulfill the first and second order needs of Maslow’s hierarchy described above (Yu, 2022). This struggle creates an underclass of people who are unable to meet their basic healthcare and safety needs. Given that the proposed business plan seeks to bridge this gap, underserved populations in low-income neighborhoods will benefit from the services offered by the proposed business (Wang et al., 2020). This target market comprises of immigrants, minorities, the uneducated, and people who earn low wages (PWC, 2022). The benefits to be accrued from the proposed business startup will be represented through improved access to quality and affordable goods and services (Harel, 2021). Therefore, customers would be able to buy products and services that were previously out-of-reach.

Pain Points

This section of the analysis highlights challenges that are likely to be encountered when implementing the proposed business plan. Culture is likely to be one of those pain points because the success of an on-demand product delivery business requires behavioral changes among customers to create a critical mass of customers (Prasad, Kiran and Sharma, 2021). Culture is mentioned as a pain point because the target market is familiar with the practice of buying medicine over the counter and not using smartphones. Therefore, for the proposed business to work as intended, prospective customers need to undergo behavioral change modifications to internalize the new system of product delivery.

At the same time, customers will be expected to be familiar with the practice of scanning their prescriptions and uploading them on the company’s portal before ordering a product. This action is different from conventional practices of ordering medicine because most customers visit physical shops with their prescriptions to purchase medicine over the counter (Davies et al., 2018). Given that the proposed business will require them to complete the same process online, behavior change modifications are necessary to complete the transition. Overall, these insights demonstrate that overcoming consumer cultural practices will be a pain-point for the proposed business idea.

Value Proposition Formulation

The success of a business plan depends on the value it creates and offers to its customers. In this section of the report, the value proposition plan is based on the value proposition canvas described in Table 6.2 below.

Table 6.2: Value Proposition Canvas

Customer ProfileValue Proposition
PainsCustomer JobsGainsGain CreatorsPain RelieversProducts and Services
Authenticating prescriptionsImproved access to affordable medicineSpeedy Delivery of MedicineAccess to customer data poolEasy identification of patient history and diagnosisService App
Signing up for serviceDelivery of medicineConvenience in delivery of medicineAccess to high quality and affordable pharmaceutical productsIncreases community participation in business developmentOnline ordering
Convenient sign-up
Easy follow-up
Local business knowledge developmentPartnerships with local firmsDelivery agents

Details relating to the business and customer segments highlighted above are discussed in subsequent sections.

Customer Jobs

Customer jobs to be addressed in the business service plan relate to problems that customers are trying to solve. In the context of the present business plan, the value proposition for the proposed firm is convenience and affordability. These factors are included in the current review because it will provide virtual services conveniently and affordably (Davidow, 2021). Convenience will be realized when customers receive their goods without leaving their homes or offices. In this regard, they can focus on completing other tasks because they will be saving the time it would take to visit a physical pharmacy shop.

Gains

The proposed business enterprise is expected to register gains in growth when economies of scale are harnessed and exploited. However, this is a long-term value proposition plan and is likely to be realized when the proposed business has been operational for more than two years. This duration represents the standard turn-around time that small businesses are likely to register profitability (Ding and Lu, 2017). Comparatively, customers are likely to benefit from the speedy and convenient delivery of medicine.

Products and Services

The products and services highlighted in this paper refer to factors, which underpin the creation of value for the customers. Relative to this statement, the service application software and its online ordering functionality would create a technological product that suits the needs of customers. From a business perspective, local agents will be recruited to transport medicine in low-income neighborhoods. Broadly, there will be consistency in service and value development across business and functional fronts.

Solution Design

This section of the document defines the design for implementing the proposed business idea. Key issues that will be discussed in this segment of the analysis involve understanding the contribution to be made by the users and product service features that will be associated with the main brand offering. At the end of this analysis, additional insights about challenges and opportunities presented by the business design and mechanisms for including feedback will be included in the analysis. However, before undertaking this probe, it is important to understand key insights that led to the formulation of the solution design in the first place.

Key Insights Leading to the Solution Design

The solution design plan of the proposed business idea will center on understanding the role and experiences of customers when buying medicine as the main basis of strategy development. The convenience customers will enjoy from doing so, and the legal regime governing the sale and delivery of such products are also important considerations.

User’s Contribution to the Design

A business design is expected to take into consideration several factors that would affect demand and supply sides of the business plan. For purposes of this analysis, the focus of the study is on the demand side of the business plan, which is moderated by user contributions. In this review, plans for integrating the contribution of users to the overall business design will be discussed. The priority areas will be patients’ safety and the convenience of service delivery that they will enjoy by using the company’s service. In terms of safety, attention is paid to the legal regime governing the sale of medicine and changes that pharmacies have to make to accommodate proposed changes (Sehgal et al., 2021). Notably, of importance to this analysis is the requirement in law that medicine should be sold after a patient presents a prescription (Baracaldo-Santamaría, Pabón-Londoño and Rojas-Rodriguez, 2022). This legal provision will influence the design of the service plan because customers will be required to upload scanned copies of their prescriptions on an online portal before order confirmation. Again, the aim of doing so is to comply with the existing legal structure governing the sale of medicine in the UK (Pitts and Le Louet, 2018). However, by extension, the safety of medicine sold to customers will be safeguarded through this design feature. Its inclusion in the service design means that the new business will be compliant to existing laws and policies governing the sale of medicine.

The second feature to be integrated in the service design will seek to optimize the potential for offering convenient services to customers. This design feature was integrated in the service design because customers indicated that convenience was the main differentiation feature between the new business and existing ones. This view was extrapolated from the researcher’s interaction with business owners. Furthermore, as highlighted in this business plan, convenience differentiated brick-and-mortar business models from online ones (Al-Kwifi, Farha, and Zaraket, 2020). Therefore, customers will be assured that if they place an order at any given point in time, they should expect the medicine to be delivered expeditiously. Consistent with this approach, a 2-hour time allocation will be included in the service design to represent the average time that customers should wait to have products delivered to their homes. Figure 7.1 below summarizes key features of the service design

Solution design
Figure 7.1: Solution design

Product Service Features

As highlighted in this study, the new business idea will be based on the on-demand medicine delivery model. Unlike other companies that sell only over the counter drugs, the proposed business will be sell different types of medicine, including those that need a prescription. The justification for including these kinds of products in the service plan is rooted in the quest to provide underserved populations with various types of drugs. Figure 7.2 below shows the procedures for offsetting the product and service features of the pharmaceutical products to be sold.

Product and Service Features 
Figure 7.2: Product and Service Features

Given the sensitivity of medicine as a human health product, no modifications will be made to the pharmaceutical products. Indeed, the business value proposition is on delivery and not product development. However, a robust on-demand delivery system would ensure that medicine is sorted and dispatched in a timely manner.

Design Challenges and Limitations

It is important to recognize challenges and limitations of new businesses because they define boundaries that have to be overcome when in operation. The major challenge associated with the proposed business plan is its limited software outreach. The initial software application will be available for Android smartphone users. The product will be available to other users within months. Therefore, non-android phone users are likely to be excluded from the business plan for the first few months of business operation until new modifications to the service plan are implemented and other users included.

Prototype or Minimum Viable Product

Prototypes are important in defining the expectations of business owners regarding the success or failure of a business idea. To this end, a product prototype for the on-demand business plan will be developed in the first six months of operation and a test-run conducted to see if the application functions correctly. The analysis will be undertaken in a focus group setting where users will share their experiences using the company’s services. Emphasis will be made to evaluate a mobile payment option that will be used to facilitate payments and the rate of market success within specific neighborhoods. The focus review will similarly include the views of transport agents who will share the experiences of 20 riders who are expected to serve a 15- mile radius of market outreach. This feedback will be integrated back into the original plan. Figure 7.3 below shows a prototype of the product packaging design for dispatch.

Medicine Packaging 
Figure 7.3: Medicine Packaging

User Feedback and Iteration

As highlighted above, consumer feedback will be invaluable in shaping the proposed business plan. Therefore, user feedback and iteration will be key parts of the proposed enterprise project. Furthermore, this feedback will be used to improve the value proposition of the firm because continuous improvement will be a key part of the overall business strategy. Therefore, consumer feedback will play a critical role in designing the service plan for the business.

Business Model

Business Model Canvas

The operational model for the proposed business will be designed using the business model canvas framework. It highlights the fundamental building blocks of the new enterprise start-up. As highlighted in Table 8.1 below, the main considerations of the business are centered on understanding the role of key partners, their activities in new business development, resources required to secure their support, and their general profiles in enterprise planning.

Table 8.1: Business model canvas

Key PartnersKey ActivitiesValue PropositionKey ResourcesCustomer Profile
  • Brick-and mortar pharmacy stores
  • Selling and distributing medicine
  • Business streamlining will keep costs lows
  • Convenience
  • Affordability
  • Financial Resources
  • Human Resources
  • Business networks
  • Residents of low-income neighborhoods in the UK
  • Customers
  • Providing Feedback
  • Increasing awareness of business
  • Product/Service design improvements
  • Social Media
  • Underserved populations
  • Banks
  • Provision of financial support
  • Supplementing capital requirements
  • Business collateral
  • Financial institutions lending top SMEs
Route to MarketChannelsCost StructureRevenue Streams
  • Social Media
  • Telephones
  • Mobile Phone Applications
  • Fixed costs -30%
  • Variable costs – 70%
  • Marketing on merchandise
  • Drug sales
  • People who buy goods online

The model presented above takes into consideration the role of the new business in improving the healthcare standards of the target population. Likewise, it includes the opportunities for leveraging economies of scale through the integration of customer feedback in strategy development. Collaborating with key partners emerges as an important function of the business plan because it will help in expanding the market (customers), supplementing the business budget (banks), and gaining market information (pharmacies). The level of engagement with these business partners will depend on the availability of resources needed for implementation.

Summary Discussion

As highlighted above, the proposed business plan will canvas the benefits of adopting a hybrid sales and planning model that involves the inputs of multiple players. The main tenets of the business model are fixated on implementing some of the advantages of brick and mortar as well as online business models. The model takes into account the business path for generating market interest during the start-up phase, as well as for partners whose involvement in the business is to complement the primary function of providing underserved populations with quality and affordable pharmaceutical products.

Business Strategy

Project’s Vision and Mission

An organization’s vision and mission are important drivers of corporate performance. They define the boundaries of a business’s operations and the goal it intends to achieve. In line with this vision, the Porter’s five force analysis model will be used to analyze the market environment. The vision of the proposed business plan will be to promote equality in the delivery of healthcare services. The mission is to make sure that every household has access to affordable and high quality medicine. It is supported by the desire to provide essential services to underserved people who have been neglected due to their socioeconomic circumstances. This mission provides grounds for spurring investments in local enterprise development and fulfilling a greater vision of improving the lives and welfare of underprivileged people. The on-demand virtual business model provides the differentiation strategy for actualizing the vision and mission of the new start-up plan.

Strategic Priorities

Based on the primary and secondary findings gathered in this study, it is important for the proposed business to identify strategic priorities in new business development that will enhance the company’s success. This exercise is important in establishing areas to direct resources to meet key objectives (Rimmler et al., 2022). In lieu of this goal, two strategic priorities emerged from this investigation – convenience and cost. Convenience is included in this review as a strategic priority because it complements the value proposition of the business, which is to avail pharmaceutical products to low-income households, without experiencing the trouble of going to a physical shop. Therefore, convenience is a strategic priority for the proposed business plan because it differentiates the service idea from those of competitors who operate brick-and-mortar stores.

Comparatively, cost is another strategic priority for the proposed business idea because it serves low-income consumers. This group of buyers is often price-conscious and sensitive to slight changes in the cost of buying products and services (Yunus et al., 2021). Additionally, it is important to recognize the challenges that most low-income dwellers experience when trying to meet basic needs. Therefore, while healthcare services are important for the sustenance of life, it is likely that some customers would opt to redirect their resources towards meeting basic needs. Consequently, price could be a catalyst for this change or a deterrent of the same. Thus, it is included in the current probe as an area of strategic focus because low-income consumers are price-sensitive.

Market Entry Strategy

In line with the 4Ps of marketing, the market entry strategy for the proposed business will include four elements of strategic planning – product, place, price, and promotion strategies. These elements of strategic intent have been used in several marketing literatures to highlight key areas that business owners have to consider when developing their strategic plans (Kotler, 2020). The details relating to each aspect of the plan are highlighted below.

Product Strategy: The product strategy for the proposed business idea stems from the findings of the literature review section outlined in section 2 of this document. Pain relief and allergy products will be the main items sold in the new business because they account for a majority of pharmaceutical sales today (Proprietary Association of Great Britain, 2022). Indeed, statistics suggest that there has been a 2.7% increase in the sales of pain relief medicine since the year 2020 (Proprietary Association of Great Britain, 2022). Comparatively, there has been a 5.8% increase in the sales of allergic products within the same year (Proprietary Association of Great Britain, 2022). The Porter’s five-force analysis indicated that there is a low threat to substitute products in the market. Therefore, the main product value created for customers will be in on-demand service delivery.

Promotion Strategy: The business promotion strategy to be included in the new enterprise plan will encompass a combination of online and offline techniques. Both techniques are included in the plan because the Porter’s five force analysis indicated a high level of competitive rivalry in the market. Online techniques will involve promoting the business through social media and websites (Ali Abbasi et al., 2022). Comparatively, the offline marketing plan will include word-of-mouth communication and physical visits to stores. The latter part of the promotion campaign will be achieved when the business owner partners with established brick-and-mortar firms.

Place Strategy: The place strategy of a product refers to the platform where goods are sold or availed to customers. As highlighted in this study, the proposed business idea involves the development of an on-demand virtual platform where consumers can order for goods online. Thus, the place strategy is based on this virtual outreach plan because customers will be expected to download an application on their smartphones and register for services, based on their geographical location. This place strategy is consistent with the low supplier bargaining power highlighted in Porter’s five-force analysis. Indeed, as indicated by some of the business owners sampled in this study, the on-demand business model contains superior features of service delivery that the brick-and-mortar model lacks.

Price Strategy: The risk assessment framework for the proposed enterprise plan will be used to determine the appropriate pricing model for the business. Nonetheless, according to the feedback received from the respondents, a low-cost business strategy is suitable for the selected market. This plan is consistent with the findings of the Porter’s five–force analysis, which indicated a high competitive rivalry in the market and a moderate consumer bargaining power. Therefore, the low-cost pricing plan aligns with the income potential of the target market because it strives to provide medicine affordably. Thus, it can be assumed that the medicine sold on the platform will be affordable.

Potential Growth Strategy

The growth strategy for the proposed business plan was developed using the Ansoff matrix. It helps businesses to determine their growth strategies after assessing the levels of risk involved (Peterdy, 2022). Figure 9.1 below highlights different strategic options that business managers follow when venturing into new markets.

Ansoff matrix 
Figure 9.1: Ansoff matrix

As demonstrated above, the process of strategy determination is accomplished by evaluating a product’s profile with market uncertainties. According to the above-mentioned classification style, business owners can adopt four strategies of strategy development – market penetration, product development, diversification, and market development (Peterdy, 2022). Given that the proposed business plan aims to serve members of low-income communities, a diversification strategy cannot work because low-income residents are part of the existing pharmaceutical market.

A market penetration strategy is inappropriate for use in the current study because the goal of the business is not to increase sales – the strategy intends to achieve this aim. Likewise, a product development plan cannot be implemented because the business focus will be on delivery of medicine and not on its development. Therefore, a market development strategy will be implemented in the propose business because it focuses on selling existing products to new markets (Peterdy, 2022). The existing products to be sold in the current business plan are pharmaceutical products, while the new market is low-income residents.

Project Viability

Resource Requirements

Resources are necessary in implementing effective business plans. Indeed, firms that lack sufficient means of production are unlikely to meet their objectives because they will be vulnerable to adverse market elements. Relative to this assertion, the resources affiliated with the proposed business strategy are highlighted below.

Labor: The proposed business will include the services of 20 riders and five people doing office work. It is projected that these five employees will be recruited during the initial phase of the business to address customer service needs, manage the business, and process orders. It is anticipated that the first year of operation will have a low number of sales. Therefore, the proposed number of employees is not expected to increase until the completion of the first year of business.

Capital: Capital resources refers to financial support availed to businesses to start operations. The initial phase of the business development plan will require intensive capital injection in the development of a smartphone application. Later, the business’s financial resources will be used to rent office space and pay employees.

Equipment: A share of the company’s financial resources will be used to buy equipment that will be used to run the proposed business. Particularly, the initial capital injection to the business will be used to buy motorcycles that will be used to deliver medicine to customers. Additionally, some resources will be used to buy uniform for the riders and other company employees. Each employee will also be equipped with a mobile phone that will be used for internal company communication.

Sharing Economy Canvas

An important observation made from the operations of other on-demand pharmacies is the importance of partnering with local businesses to provide services. To this end, the proposed business will be implemented by partnering with local pharmacies to market the company’s services. It is expected that word-of-mouth communication will be used to create the initial critical mass of respondents that will buy the company’s products. Therefore, the sharing economy canvas of the business plan will be limited to promoting the marketing activities of the firm.

Potential Source of Finances

The new enterprise start-up will be financed using a combination of several methods. They include crowd funding, venture capital, personal savings, and business loan. Each source of finance is expected to contribute 25% of the cost of doing business. A shared contribution models is adopted to supplement the financial shortfall that emerges from the use of personal financing. The model will equally be used to cover unforeseen costs in the business implementation plan. Therefore, each source of finance will have different objectives to accomplish. The personal finance option will be used to pay for office space and workers’ salaries for the first six months. Comparatively, the loan from the financial institution will be employed to pay for software development. Other sources of finance will be used for equipment and administrative purposes.

Financial Statements

In this section of the analysis, a proposed balance sheet, profit and loss statements, and income statement for the proposed business are provided. They highlight estimated financial projections for the new enterprise plan.

Profit and Loss Statement

RevenuesCost20232024
Sales$ 500,000
Income from partnerships$ 100,000
Promotions$ 100,000
Total Revenue$700,000$800,000
Expenses
Cost of goods sold$ 300,000
Rent$ 5,000
Wages$ 15,000
Total$320,000$420,000
Profit/Loss$380,000$380,000

Income Statement

20232024
Revenue$9,000$18,000
Cost of Sales$5,000$10,000
Gross Profit$4,000$8,000
Expenses
Administrative expenses$1,000$1,000
Operating Income$3,000$7,000
Interest Expense(100)(200)
Income before taxes$2,900$6,800

Balance Sheet

Current Assets20232024
Equipment$200,000$300,000
Inventory$100,000$100,000
Cash and cash equivalent$50,000$53,000
Liabilities
Accounts Payable100,000100,000
Balance BF250,000250,000

The above-mentioned calculations are based on the assumption that $500,000 will be used to start the proposed enterprise. The figures mentioned above are designed to fit this budget and recoup the capital in a short time. The revenue projections are based on the average estimated revenue from pharmaceutical companies operating in the target market. This information was obtained from interacting with business owners in the low-income settlements of the UK

Strategic Risk Management

A strategic risk assessment is an important tool for protecting a new business from adverse market events. To this end, an insurance policy against medical negligence will be taken to protect the business from lawsuits. This type of protection will be renewed at different stages of the business life cycle to reflect varied risk profiles of the business. Therefore, it is expected that premiums will vary depending on the circumstances or risk profile in question. The strategic risk assessment framework highlighted in Figure 11.1 below will be relevant in managing risks through an iterative process where risk centrally links capital and return.

Table 11.1: Risk Assessment Framework

Type of Risk and PrioritySourceHow to mitigate
1. StrategicPartnershipsConducting due diligence
2. CompliancePrescriptionsPrescription validation
3. OperationalImplementing on-demand business modelAutomation

Operational and strategic risks will be mitigated through improved efficiency as the business develops. At the same time, compliance standards are set to increase in this manner. The use of online techniques for business management is also expected to minimize operational risks. Overall, risk will be minimized by maintaining the financial soundness of the business.

Conclusion

This study has discussed the prospects of setting up a new enterprise aimed at selling and distributing medicine to residents of low-income communities in the UK. The business idea was conceived from the backdrop of the failure of existing healthcare plans to effectively meet the needs of underserved populations. Therefore, the main value proposition posed by the new business is the reduction of inequality in the sale and distribution of medicine. The business idea was developed with the aim of exploiting an existing market opportunity of automation, which is increasingly defining business operations in the pharmaceutical industry.

The business plan will be implemented using a virtual business model, which accommodates all business activities in a smartphone or computer. Therefore, customers can simply order for medicine using their mobile phones or computers and have the drugs delivered to them. The service design of the new business plan takes into account some of the challenges of implementing such a business plan. One of the main issues is the lack of cultural familiarity with the practice of ordering medicine online. This concern stems from the socialization of members of low-income communities to purchase their drugs over the counter. The new business model exploits a new trend of automation in the healthcare industry, which seeks to facilitate online pharmaceutical sales.

Reference List

Abreu-Afonso, J. et al. (2022) ‘How couple’s relationship lasts over time? a model for marital satisfaction’, Psychological Reports, 125(3), pp. 1601–1627.

Ali Abbasi, G. et al. (2022) ‘Determinants of SME’s social media marketing adoption: competitive industry as a moderator’, SAGE Open, 8(2), pp, 112-132.

Al-Kwifi, O. S., Farha, A. K. A. and Zaraket, W. S. (2020) ‘Competitive dynamics between multinational companies and local rivals in emerging markets’, FIIB Business Review, 9(3), pp. 189–204.

Alonzo, D., Popescu, M. and Zubaroglu, P. (2022) ‘Mental health impact of the Covid-19 pandemic on parents in high-risk, low income communities’, International Journal of Social Psychiatry, 68(3), pp. 575–581.

Alzougool, B. (2018) ‘The impact of motives for Facebook use on Facebook addiction among ordinary users in Jordan’, International Journal of Social Psychiatry, 64(6), pp. 528-535.

Assefa, M. (2021) ‘COVID-19 lockdown restrictions and small business survival strategy: government supporting schemes’, Business Perspectives and Research, 7(1), pp. 547-554.

Association of the British Pharmaceutical Industry. (2020) . Web.

Bailey, J. et al. (2019) ‘Getting at equality: research methods informed by the lessons of intersectionality’, International Journal of Qualitative Methods, 6(2), pp. 1-14.

Banal-Estañol, A., Newham, M. and Seldeslachts, J. (2021) ‘Common ownership in the U.S. pharmaceutical industry: a network analysis’, The Antitrust Bulletin, 66(1), pp. 68–99.

Baracaldo-Santamaría, D., Pabón-Londoño, S. and Rojas-Rodriguez, L. C. (2022) ‘Drug safety of frequently used drugs and substances for self-medication in COVID-19’, Therapeutic Advances in Drug Safety, 6(3), pp. 428-439.

Barshikar, R. (2020) ‘Covid 19 – Impact and new normal for pharmaceutical industry’, Journal of Generic Medicines, 16(3), pp. 112–119.

Bhaduri, S. (2018) ‘Pharmaceutical industry in the global South: introduction to special issue’, Science, Technology and Society, 23(3), pp. 7–8.

Cheng, W. et al. (2020) ‘Satisfaction and needs of pharmacists in prescription-checking training: a cross-sectional survey’, Journal of International Medical Research, 6(3), pp. 378-383.

Chopra, A., Avhad, V. and Jaju, S. (2021) ‘Influencer marketing: an exploratory study to identify antecedents of consumer behavior of millennial’, Business Perspectives and Research, 9(1), pp. 77–91.

Co-op Delivery. (2022) Co-op food delivered within 2 hours. Web.

Cotter, K. et al. (2021) ‘“Reach the right people”: the politics of “interests” in Facebook’s classification system for ad targeting’, Big Data and Society, 6(1), 1-11.

da Silva Frost, A. and Ledgerwood, A. (2020) ‘Calibrate your confidence in research findings: A tutorial on improving research methods and practices’, Journal of Pacific Rim Psychology. 5(1), pp. 456-477.

Davidow, M. (2021) ‘Gautam Mahajan and Walter Vieira, customer value starvation can kill’, Journal of Creating Value, 7(1), pp. 135–139.

Davies, S. J. C. et al. (2018) ‘Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013’, Therapeutic Advances in Psychopharmacology, 7(2), pp. 99–114.

De Mooij, M. (2019) Consumer behavior and culture: consequences for global marketing and advertising. London: SAGE Publications Limited.

Dhanora, M., Sharma, R. and Park, W. G. (2021) ‘Technological innovations and market power: a study of Indian pharmaceutical industry’, Millennial Asia, 12(1), pp. 5–34.

Ding, Y. and Lu, H. (2017) ‘The interactions between online shopping and personal activity travel behavior: an analysis with a GPS-based activity travel diary’, Transportation, 44(2), pp. 311-324.

Ditrich, L. and Sassenberg, K. (2017) ‘Kicking out the trolls – antecedents of social exclusion intentions in Facebook groups’, Computers in Human Behavior, 75(2), pp. 32-41.

Doherty, B, M. (2019) ‘Racial and ethnic differences in consumers’ economic expectations’, Socius, 7(2), pp. 1-10.

du Plessis, C. (2022) ‘A scoping review of the effect of content marketing on online consumer behavior’, SAGE Open, 6(2), pp. 1-12.

Ertel, S. (2021) ‘Small business post–COVID-19: motivational needs through uncertain times’, Compensation & Benefits Review, 53(1), pp. 8–15.

European Environmental Bureau. (2018) . Web.

Eze, S. C., Chinedu-Eze, V. C. A. and Awa, H. O. (2021) ‘Key success factors (KSFS) underlying the adoption of social media marketing technology’, SAGE Open, 11(2), PP. 1-12.

García-Canal, E. et al. (2018) ‘Imprinting and early exposure to developed international markets: the case of the new multinationals’, Business Research Quarterly, 21(3), pp. 141–152.

Gatersleben, B. et al. (2019) ‘Moral, wasteful, frugal, or thrifty? Identifying consumer identities to understand and manage pro-environmental behavior’, Environment and Behavior, 51(1), pp. 24–49.

Gates, S. et al. (2019) . Web.

Hansford, L., Thomas, F. and Wyatt, K. (2022) ‘How does housing affect end-of-life care and bereavement in low-income communities? A qualitative study of the experiences of bereaved individuals and service providers in the United Kingdom’, Palliative Care and Social Practice, 9(2), pp. 211-223.

Harel, R. (2021) ‘The impact of COVID-19 on small businesses’ performance and innovation’, Global Business Review, 3(1), pp. 168-176.

Harris, B. et al. (2021) ‘Mobile consulting as an option for delivering healthcare services in low-resource settings in low- and middle-income countries: a mixed-methods study’, Digital Health, 6(2), pp. 223-231.

Jose, J. (2020) ‘Communication on drug safety-related matters to patients: is it even more significant in this digital era?’, Therapeutic Advances in Drug Safety, 8(3), pp. 957-987.

Kamiike, A. (2020) ‘The TRIPS agreement and the pharmaceutical industry in India’, Journal of Interdisciplinary Economics, 32(1), pp. 95–113.

Kampf, C. E. (2018) ‘Connecting corporate and consumer social responsibility through social media activism’, Social Media and Society, 7(2), pp. 116-123.

Köhler, T., Smith, A. and Bhakoo, V. (2019) ‘Feature topic for ORM: “templates in qualitative research methods”’, Organizational Research Methods, 22(1), pp. 3–5.

Kotler, P. (2020) ‘Marketing and value creation’, Journal of Creating Value, 6(1), pp. 10–11.

Lazic, S. E. and Williams, D. P. (2020) ‘Improving drug safety predictions by reducing poor analytical practices’, Toxicology Research and Application, 3(2), pp. 341-348.

Lê, J. K. and Schmid, T. (2022) ‘The practice of innovating research methods’, Organizational Research Methods, 25(2), pp. 308–336.

Lee, N. R. (2020) ‘The future of social marketing: let’s get it in orbit by 2025!’, Social Marketing Quarterly, 26(1), pp. 3–13.

Lee, Y. et al. (2019) ‘Why do experts solve complex problems using open innovation? Evidence from the U.S. pharmaceutical industry’, California Management Review, 62(1), pp. 144–166.

Li, J., Dostie, B. and Simard-Duplain, G. (2022) ‘Firm pay policies and the gender earnings gap: the mediating role of marital and family status’, ILR Review, 7(2), pp. 453-462.

Li, J. et al. (2021) ‘Conformity consumer behavior and external threats: an empirical analysis in China during the COVID-19 pandemic’, SAGE Open, 7(2), pp. 449-451.

Martin, R. W. et al. (2017) ‘Comparison of the effects of a pharmaceutical industry decision guide and decision aids on patient choice to intensify therapy in rheumatoid arthritis’, Medical Decision Making, 37(5), pp. 577–588.

Mehta, S., Saxena, T. and Purohit, N. (2020) ‘The new consumer behaviour paradigm amid COVID-19: permanent or transient?’, Journal of Health Management, 22(2), pp. 291–301.

Miller, D., Wiklund, J. and Yu, W. (2020) ‘Mental health in the family business: a conceptual model and a research agenda’, Entrepreneurship Theory and Practice, 44(1), pp. 55–80.

Morelato, M. et al. (2020) ‘An insight into the sale of prescription drugs and medicine on the AlphaBay cryptomarket’, Journal of Drug Issues, 50(1), pp. 15–34.

Morris, C. (2022) ‘Negotiating ambiguous substance use: UK newspaper representations of self-prescribing medicinal cannabis use in the 1990s’, Journal of Drug Issues, 8(2), pp. 1-10.

Netmed. (2022) Payment partner offers. Web.

Newman, A., Obschonka, M. and Block, J. (2022) ‘Small businesses and entrepreneurship in times of crises: the renaissance of entrepreneur-focused micro perspectives’, International Small Business Journal, 40(2), pp. 119–129.

NowRx Inc. (2022) Frequently asked questions. Web.

Okoro, O. N., Hillman, L. A. and Cernasev, A. (2020) ‘“We get double slammed!”: Healthcare experiences of perceived discrimination among low-income African-American women’, Women’s Health, 8(5), pp. 657-671.

Pashley, D., Ozieranski, P. and Mulinari, S. (2022) ‘Disclosure of pharmaceutical industry funding of patient organisations in Nordic countries: can industry self-regulation deliver on its transparency promise?’, International Journal of Health Services, 52(3), pp. 347–362.

Peterdy, K. (2022) . Web.

Pitts, P. J. and Le Louet, H. (2018) ‘Advancing drug safety through prospective pharmacovigilance’, Therapeutic Innovation & Regulatory Science, 52(4), pp. 400–402.

Polhemus, A. M. et al. (2019) ‘Accelerating adoption of patient-facing technologies in clinical trials: a pharmaceutical industry perspective on opportunities and challenges’, Therapeutic Innovation & Regulatory Science, 53(1), pp. 8–24.

Prasad, S., Kiran, R. and Sharma, R. K. (2021) ‘Behavioural, socio-economic factors, financial literacy and investment decisions: are men more rational and women more emotional?’, The Indian Economic Journal, 69(1), pp. 66–87.

Pringsheim, T. et al. (2017) ‘Physical health and drug safety in individuals with schizophrenia’, The Canadian Journal of Psychiatry, 62(9), pp. 673–683.

Proprietary Association of Great Britain. (2022) About our industry. Web.

PWC. (2022) . Web.

Rimmler, S. et al. (2022) ‘Structural barriers to HIV prevention and services: perspectives of African American women in low-income communities’, Health Education & Behavior, 4(2), pp. 167-173.

Sarkees, M. E., Fitzgerald, M. P. and Lamberton, C. (2021) ‘The pandemic ripple effect: understanding marketing and public policy opportunities in the pharmaceutical industry’, Journal of Public Policy & Marketing, 40(1), pp. 103–104.

Sehgal, R. et al. (2021) ‘Shopping safety practices mutate consumer buying behaviour during COVID-19 pandemic’, Vision, 4(3), pp. 329-340.

Seuring et al. (2022) . Web.

Sexton, R., Nguyen, T. and Roberts, D. L. (2021) ‘The use and prescription of Pangolin in traditional Vietnamese medicine’, Tropical Conservation Science, 6(2), pp. 122-132.

Shin, N., Park, S. and Kim, H. (2021) ‘Consumer satisfaction–based social commerce service quality management’, Journal of Family History, 24(1), pp. 447–449.

Shoib, S. et al. (2022) ‘Is Maslow’s hierarchy of needs applicable during the COVID-19 pandemic?’, Indian Journal of Psychological Medicine, 44(1), pp. 98–100.

Sparkmon, W. (2020) . Web.

Statista. (2022) Consumer spending on pharmaceutical products in the United Kingdom (UK) from 2005 to 2020. Available at: (Accessed: 8 August 2022).

UK Office for National Statistics. (2021) Web.

Varma, D. and Dutta, P. (2022) ‘’, Global Business Review, 4(2), pp. 1-13. Web.

Wagner, C., Kawulich, B. and Garner, M. (2019) ‘A mixed research synthesis of literature on teaching qualitative research methods’, SAGE Open, 5(2), pp. 1-13.

Wang, Z. et al. (2020) ‘Multidimensional perspective of firms’ IT capability between digital business strategy and firms’ efficiency: a case of Chinese SMEs’, SAGE Open, 6(2), pp. 203-214.

Williamson, J. (2018) . Web.

Xian, H., Jiang, N. and McAdam, M. (2021) ‘Negotiating the female successor–leader role within family business succession in China’, International Small Business Journal, 39(2), pp. 157–183.

Xie, J. (2021) ‘Horizontal shareholdings and paragraph iv generic entry in the U.S. pharmaceutical industry’, The Antitrust Bulletin, 66(1), pp. 100–112.

Yemate Package and Printing. (2020) . Web.

Yu, T. T. F. (2022) ‘Sailing away from the pyramid: a revised visual representation of Maslow’s theory Z’, Journal of Humanistic Psychology, 4(2), pp. 1-12.

Yunus, S. Z. S. A. et al. (2021) ‘The COVID impact to public healthcare utilization among urban low-income subsidized community in Klang Valley Malaysia’, Health Services Research and Managerial Epidemiology, 7(2), pp. 112-123.

Zu, Y. and Krever, R. (2020) ‘The United Kingdom has spoken: the receding impact of European jurisprudence on the UK interpretation of the common VAT system’, Common Law World Review, 49(1), pp. 75–91.

Appendix

Appendix 1: Questionnaire

Dear Participant,

You are invited to take part in this market research to investigate the potential of starting a new on-demand delivery business for pharmaceutical products among residents of low-income communities in the UK. We seek your participation in this investigation because of your expertise as a business owner/operator in this market. This questionnaire is divided into two sections whereby the first part captures your demographic/business characteristics and the second one samples your views on various aspects of marketing strategy development for the proposed business. Please, answer the questions freely

Part A – Demographic Findings

[Please, (✔) tick on the appropriate boxes]

What is your marital status?

  • ☐ Single
  • ☐ Married
  • ☐ Widowed
  • ☐ Divorced
  • ☐ Other

What is your age?

  • ☐ 18 – 25 years
  • ☐ 26-35 years
  • ☐ 36-45 years
  • ☐ 46- 55 years
  • ☐ More than 55 years

How would you describe the ownership structure of your business?

  • ☐ Sole Proprietorship
  • ☐ Partnership
  • ☐ Family-owned
  • ☐ Corporation
  • ☐ Other

How many outlets does your business have?

  • ☐1
  • ☐ 2 -3
  • ☐4 – 5
  • ☐ 5 – 7
  • ☐More than 7

How long has your business been in operation?

  • ☐ Less than 2 years
  • ☐ 2-5 years
  • ☐ 5-7 years
  • ☐ 7-10 years
  • ☐ More than 10 years

Part B – Factor Analysis

In this part of the questionnaire, we seek your views on the best type of strategy to adopt for a new business seeking to venture into the UK pharmaceutical market. Please, tick (✔) on the option that best describes your market experiences vis-à-vis the operational issues highlighted below.

Financing Model

If I was to do it again, I would rather use my money to start my business than seek external financing

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

A scheduled payment plan is more advantageous than a one-off payment of stock

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

I would rather operate my business without external partners

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

An online marketing strategy is easier to finance than a brick-and-mortar plan

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree
Pricing

My pricing plan sustains my sales

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

My pricing strategy is significantly influenced by my competitors’ actions

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

A value-based pricing strategy would complement my business operations

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

A low-end pricing strategy is suitable for selling pharmaceutical products

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree
Validation of Prescriptions

Automating the purchasing process would improve the process of prescription validation

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

Developing tamper-resistant prescriptions methods will eliminate prescription forgeries

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

The validity of prescriptions should be left to the pharmacist’s own judgment and not those of other players

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

Complying with the law on prescription medication is necessary to sustain sales

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree
Advertisement Strategy

A digital marketing strategy effectively reaches my target market

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

A social media marketing plan would effectively reach low-income customers in the neighbourhoods

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

A digital marketing strategy complements the skills of a pharmacist in product marketing

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

Marketing my business using virtual means effectively accommodates all my marketing messages

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree
Value Addition

The use of digital marketing methods increase brand awareness of key products

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

The use of digital marketing tools helps to eliminate market redundancies hence making my business efficient

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

An on-demand business model would track the value of products from their point of production to sale

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

Adopting a value added model to my business plan would transform the flow of products from saturated markets to the underserved

  • ☐ Strongly Agree
  • ☐ Agree
  • ☐ Neither Agree nor Disagree
  • ☐ Disagree
  • ☐ Strongly Disagree

Thank you for participating in the study!

*The End*

Appendix 2 – Distribution of respondents according to marital status

Please state your marital status
FrequencyPercentValid PercentCumulative Percent
ValidSingle2337.137.137.1
Married2337.137.174.2
Widowed914.514.588.7
Divorced58.18.196.8
Others23.23.2100.0
Total62100.0100.0

Appendix 3 – Distribution of respondents according to age

What is your Age?
FrequencyPercentValid PercentCumulative Percent
Valid18-252037.137.137.1
26-351727.427.464.5
36-451422.622.687.1
46-5581.61.688.7
Older than 5534.84.8100.0
Total62100.0100.0

Appendix 4 – Distribution of respondents according to business ownership structure

How would you describe the ownership structure of your business?
FrequencyPercentValid PercentCumulative Percent
ValidSole Proprietorship1829.029.029.0
Partnership2032.332.361.3
Family-owned1727.427.488.7
Corporation58.18.196.8
Other23.23.2100.0
Total62100.0100.0

Appendix 5 – Distribution of respondents according to number of outlets operated

How many outlets does your business have?
FrequencyPercentValid PercentCumulative Percent
Valid13251.651.651.6
2-32337.137.188.7
4-534.84.893.5
5-711.61.695.2
More than 734.84.8100.0
Total62100.0100.0

Appendix 6 – Distribution of respondents according to years in operation

How long have you worked in your organization?
FrequencyPercentValid PercentCumulative Percent
ValidLess than 2 years3251.651.651.6
2-5 Years1219.419.471.0
5-7 Years1321.021.091.9
7-10 Years34.84.896.8
More than 10 years23.23.2100.0
Total62100.0100.0

Appendix 7 – Financing

Descriptive Statistics
NRangeMinimumMaximumSumMeanStd. DeviationVarianceSkewness
StatisticStatisticStatisticStatisticStatisticStatisticStd. ErrorStatisticStatisticStatisticStd. Error
Financing 1624151121.81.117.920.8471.183.304
Financing 2624151211.95.1481.1651.3581.060.304
Financing 3624151191.92.1351.0601.125.762.304
Financing 4624151432.31.1801.4212.019.496.304
Valid N (listwise)62

Appendix 8 – Pricing

Descriptive Statistics
NRangeMinimumMaximumSumMeanStd. DeviationVarianceSkewness
StatisticStatisticStatisticStatisticStatisticStatisticStd. ErrorStatisticStatisticStatisticStd. Error
Pricing 1624151011.63.126.996.9911.947.304
Pricing 2624151031.66.1341.0551.1132.199.304
Pricing 362213811.31.063.499.2491.264.304
Pricing 4624151141.84.1341.0591.1211.275.304
Valid N (listwise)62

Appendix 9 – Prescriptions

Descriptive Statistics
NRangeMinimumMaximumSumMeanStd. DeviationVarianceSkewness
StatisticStatisticStatisticStatisticStatisticStatisticStd. ErrorStatisticStatisticStatisticStd. Error
Verification 1623141071.73.103.813.661.928.304
Verification 2624151352.18.1731.3611.853.916.304
Verification 3624151282.06.1781.4011.963.917.304
Verification 4624151211.95.1431.1221.260.888.304
Valid N (listwise)62

Appendix 10 – Value addition findings

Descriptive Statistics
NRangeMinimumMaximumSumMeanStd. DeviationVarianceSkewness
StatisticStatisticStatisticStatisticStatisticStatisticStd. ErrorStatisticStatisticStatisticStd. Error
Value Addition 1624151462.35.1811.4272.036.426.304
Value Addition 2624151011.63.126.996.9911.947.304
Value Addition 362415911.47.094.740.5482.494.304
Value Addition 4624151402.26.1801.4131.998.567.304
Valid N (listwise)62

Appendix 11 – Impact of Marital Status on Findings

ANOVA
Sum of SquaresDfMean SquareFSig.
Financing 1Between Groups2.4414.610.706.591
Within Groups49.23757.864
Total51.67761
Financing 2Between Groups19.95444.9894.521.003
Within Groups62.900571.104
Total82.85561
Financing 3Between Groups10.90642.7272.694.040
Within Groups57.690571.012
Total68.59761
Financing 4Between Groups12.11743.0291.555.199
Within Groups111.061571.948
Total123.17761
Pricing 1Between Groups4.17041.0431.056.387
Within Groups56.29857.988
Total60.46861
Pricing 2Between Groups6.41341.6031.487.218
Within Groups61.474571.078
Total67.88761
Pricing 3Between Groups.3354.084.322.862
Within Groups14.84357.260
Total15.17761
Pricing 4Between Groups.3704.092.077.989
Within Groups68.017571.193
Total68.38761
Verification 1Between Groups1.1604.290.422.792
Within Groups39.17857.687
Total40.33961
Verification 2Between Groups19.56244.8912.982.026
Within Groups93.486571.640
Total113.04861
Verification 3Between Groups4.66041.165.577.680
Within Groups115.082572.019
Total119.74261
Verification 4Between Groups8.73042.1821.826.136
Within Groups68.125571.195
Total76.85561
Value Addition 1Between Groups17.13344.2832.280.072
Within Groups107.061571.878
Total124.19461
Value Addition 2Between Groups4.17041.0431.056.387
Within Groups56.29857.988
Total60.46861
Value Addition 3Between Groups3.2664.8161.543.202
Within Groups30.17057.529
Total33.43561
Value Addition 4Between Groups20.28845.0722.846.032
Within Groups101.583571.782
Total121.87161

Appendix 12 – Impact of Age on Findings

ANOVA
Sum of SquaresDfMean SquareFSig.
Financing 1Between Groups6.90051.3801.726.144
Within Groups44.77756.800
Total51.67761
Financing 2Between Groups12.23352.4471.940.102
Within Groups70.621561.261
Total82.85561
Financing 3Between Groups5.52551.105.981.437
Within Groups63.072561.126
Total68.59761
Financing 4Between Groups6.12251.224.586.711
Within Groups117.055562.090
Total123.17761
Pricing 1Between Groups4.9775.9951.004.424
Within Groups55.49156.991
Total60.46861
Pricing 2Between Groups4.0955.819.719.612
Within Groups63.792561.139
Total67.88761
Pricing 3Between Groups.5545.111.424.830
Within Groups14.62456.261
Total15.17761
Pricing 4Between Groups5.91651.1831.061.392
Within Groups62.471561.116
Total68.38761
Verification 1Between Groups4.1475.8291.283.284
Within Groups36.19256.646
Total40.33961
Verification 2Between Groups5.62851.126.587.710
Within Groups107.421561.918
Total113.04861
Verification 3Between Groups5.64951.130.555.734
Within Groups114.093562.037
Total119.74261
Verification 4Between Groups6.00251.200.949.457
Within Groups70.853561.265
Total76.85561
Value Addition 1Between Groups7.66051.532.736.599
Within Groups116.533562.081
Total124.19461
Value Addition 2Between Groups4.9775.9951.004.424
Within Groups55.49156.991
Total60.46861
Value Addition 3Between Groups3.1265.6251.155.343
Within Groups30.31056.541
Total33.43561
Value Addition 4Between Groups8.88051.776.880.500
Within Groups112.991562.018
Total121.87161

Appendix 13 – Impact of Number of Branches on Findings

ANOVA
Sum of SquaresdfMean SquareFSig.
Financing 1Between Groups1.3084.327.370.829
Within Groups50.37057.884
Total51.67761
Financing 2Between Groups2.8904.722.515.725
Within Groups79.965571.403
Total82.85561
Financing 3Between Groups8.67542.1692.063.098
Within Groups59.922571.051
Total68.59761
Financing 4Between Groups6.30641.577.769.550
Within Groups116.871572.050
Total123.17761
Pricing 1Between Groups2.8434.711.703.593
Within Groups57.625571.011
Total60.46861
Pricing 2Between Groups12.67243.1683.270.018
Within Groups55.21557.969
Total67.88761
Pricing 3Between Groups1.9044.4762.044.100
Within Groups13.27357.233
Total15.17761
Pricing 4Between Groups7.78141.9451.829.136
Within Groups60.606571.063
Total68.38761
Verification 1Between Groups2.9134.7281.109.361
Within Groups37.42657.657
Total40.33961
Verification 2Between Groups12.99843.2491.851.132
Within Groups100.051571.755
Total113.04861
Verification 3Between Groups3.2494.812.397.810
Within Groups116.493572.044
Total119.74261
Verification 4Between Groups13.69443.4243.090.023
Within Groups63.161571.108
Total76.85561
Value Addition 1Between Groups1.3234.331.153.961
Within Groups122.871572.156
Total124.19461
Value Addition 2Between Groups2.8434.711.703.593
Within Groups57.625571.011
Total60.46861
Value Addition 3Between Groups.9054.226.396.810
Within Groups32.53057.571
Total33.43561
Value Addition 4Between Groups1.0014.250.118.976
Within Groups120.870572.121
Total121.87161

Appendix 14 – Impact of Ownership Structure on Findings

ANOVA
Sum of SquaresDfMean SquareFSig.
Financing 1Between Groups12.39243.0984.495.003
Within Groups39.28557.689
Total51.67761
Financing 2Between Groups6.84341.7111.283.287
Within Groups76.012571.334
Total82.85561
Financing 3Between Groups5.08741.2721.141.346
Within Groups63.510571.114
Total68.59761
Financing 4Between Groups14.60143.6501.916.120
Within Groups108.577571.905
Total123.17761
Pricing 1Between Groups3.7094.927.931.452
Within Groups56.75957.996
Total60.46861
Pricing 2Between Groups14.98943.7474.038.006
Within Groups52.89857.928
Total67.88761
Pricing 3Between Groups1.8514.4631.979.110
Within Groups13.32757.234
Total15.17761
Pricing 4Between Groups.4674.117.098.983
Within Groups67.920571.192
Total68.38761
Verification 1Between Groups3.0534.7631.167.335
Within Groups37.28557.654
Total40.33961
Verification 2Between Groups4.88641.222.644.634
Within Groups108.162571.898
Total113.04861
Verification 3Between Groups5.21041.302.648.630
Within Groups114.532572.009
Total119.74261
Verification 4Between Groups1.2404.310.234.918
Within Groups75.615571.327
Total76.85561
Value Addition 1Between Groups17.02944.2572.264.073
Within Groups107.165571.880
Total124.19461
Value Addition 2Between Groups3.7094.927.931.452
Within Groups56.75957.996
Total60.46861
Value Addition 3Between Groups2.3154.5791.060.385
Within Groups31.12157.546
Total33.43561
Value Addition 4Between Groups18.84444.7112.606.045
Within Groups103.027571.807
Total121.87161

Appendix 15 – Impact of Years of Operation on Findings

ANOVA
Sum of SquaresDfMean SquareFSig.
Financing 1Between Groups.8184.205.229.921
Within Groups50.85957.892
Total51.67761
Financing 2Between Groups5.62741.4071.038.396
Within Groups77.228571.355
Total82.85561
Financing 3Between Groups2.3474.587.505.732
Within Groups66.250571.162
Total68.59761
Financing 4Between Groups10.10642.5271.274.291
Within Groups113.071571.984
Total123.17761
Pricing 1Between Groups2.1854.546.534.711
Within Groups58.283571.023
Total60.46861
Pricing 2Between Groups1.5664.391.336.852
Within Groups66.321571.164
Total67.88761
Pricing 3Between Groups.8504.212.845.503
Within Groups14.32857.251
Total15.17761
Pricing 4Between Groups9.25842.3152.231.077
Within Groups59.129571.037
Total68.38761
Verification 1Between Groups2.0254.506.753.560
Within Groups38.31457.672
Total40.33961
Verification 2Between Groups9.76642.4411.347.264
Within Groups103.283571.812
Total113.04861
Verification 3Between Groups7.10041.775.898.471
Within Groups112.642571.976
Total119.74261
Verification 4Between Groups2.3364.584.447.774
Within Groups74.519571.307
Total76.85561
Value Addition 1Between Groups8.59142.1481.059.385
Within Groups115.603572.028
Total124.19461
Value Addition 2Between Groups2.1854.546.534.711
Within Groups58.283571.023
Total60.46861
Value Addition 3Between Groups.3064.077.132.970
Within Groups33.12957.581
Total33.43561
Value Addition 4Between Groups8.33842.0851.047.391
Within Groups113.533571.992
Total121.87161

Appendix 16 – Ethical Approval Form

Section A: Student Declaration

In completing this Declaration, I am confirming that:

  • The Ethical Clearance Form I am submitting for my project is accurate to the best of my knowledge and belief
  • If the project is not approved, I will not carry out any primary research
  • If the project is approved, it will adhere to UCB Research and Ethics guidelines at all times
  • If the project is approved, I will not change the research design without first discussing it with my lecturer or supervisor
  • I will inform UCB immediately if anyone makes a complaint about the content or conduct of the primary research
  • I understand that I may be subject to UCB disciplinary procedures for non-compliance

Name of Student:__________________________________

Email Address: _______________________________________

Mobile:_______________________________________________________

Full ID Code:_____________________________________________________

Programme registered for:__________________________________________________________

Module registered for:_________________________________________________________

Name of Lecturer or Supervisor:_____________________________________________________

Proposed Research Title:

I am applying for (cross one): Secondary-only research

Primary and Secondary research☒

Section B: Application for Ethical Clearance Form

You must answer all questions in this section

Please tickYESNO
1. Does your research involve participants who are particularly vulnerable or unable to give informed consent?
2. Will it be necessary for participants to take part in your research without their knowledge/consent? (e.g. an observation study)
3. Does your research involve children or young people under the age of 18?
4. Will your research involve discussion of topics that the participants might find sensitive (e.g. sexual activity, alcohol/drug use, discrimination issues)?
5. Will your research involve prolonged or repetitive physical or psychological testing?
6. Will your research involve physical examinations and/or the use of medical records/reports?
7. Could your research induce psychological stress, anxiety, cause harm, or negative consequences?
8. Will financial inducements of any kind be offered to participants?
9. In terms of personal safety, are you putting yourself and/or your participants at risk in any way? (e.g., out alone at night, interviewing in your or your participant’s home, carrying out research in unpredictable or sensitive situations)
10. Will your research involve the production of recorded media such as audio and video recordings?
11. Do you propose to carry out primary research in a place of work or survey/interview staff of a specific organisation by any other means?
12. Will any non UCB staff have access your results/data?
13. Will your research involve using online chat rooms, forums or blogs?
14. Will you have access to personal information that allows you to identify individuals, or to corporate and company information that is not covered by GDPR?
15. Does the research present any environmental risks?
16. Are there any ethical issues raised by your research that you think requires further ethical consideration and review?
Will your research involve discussion of topics that the participants might find sensitive (e.g. sexual activity, alcohol/drug use, discrimination issues)?

Yes – the proposed investigation will involve access to anonymous medical data that will be obtained through health records that have been entrusted to pharmacies. It will be necessary to access such information because the lack of access to patient health records by community pharmacies could negatively impact healthcare service delivery and quality (Pires, 2022). If you have answered ‘yes’ to any of the 16 questions above, use the space below to refer to each ‘yes’ in turn and explain how you will ensure that your research complies fully with UCB Research and Ethical guidelines

Do you propose to carry out primary research in a place of work or survey/interview staff of a specific organisation by any other means?

Yes – the present investigation will be conducted in pharmacies because they have access to patients’ histories of diagnosis, laboratory results, and other materials that are relevant in developing a business plan for the new enterprise start-up.

Will your research involve using online chat rooms, forums or blogs?

Yes – the proposed research investigation will involve the use of online chat rooms as part of the data collection strategy. It will be necessary to use these virtual forums in the research to gain access to respondents who would take part in the study.

Section C: Methodology and Planning

In this section provide a brief outline of your methodology and, if appropriate, the chosen statistical procedure you are going to use. If you are planning primary research you should also upload a sample data collection sheet, questionnaire, focus group/interview questions, consent letters etc. to the appropriate area on Canvas for your module.

The proposed research project is designed to synthesize both primary and secondary data. Primary information will be obtained from 62 business persons who own or manage pharmacies in three low-income neighborhoods in the UK. The researcher will recruit them using the snowball sampling method and analyze their views using the Statistical Packages for the Social Sciences (SPSS) software – version 25. This type of data will be collected using the survey method and a questionnaire deployed to capture the respondents’ sentiments about the research topic (see appendix). This type of data will be instrumental in understanding the relationship among five areas of business operations that are relevant to the proposed business plan – financing, pricing, prescription validation, advertising, and value addition.

Comparatively, secondary data will be obtained from credible sources of academic information, including books, journals, and trustworthy websites. Materials that were published in the last five years (2017-2022) were included in the investigation, while those that did not meet this criterion were excluded from the probe due to their perceived low relevance to the current market dynamics of the proposed business idea. Collectively, both primary and secondary information sources will play a significant role in developing the design of the proposed business plan.

Section D: NHS Health Research Authority (HRA)

Please note that NHS HRA review is generally required where research involves NHS patients, NHS staff, or NHS facilities. Please also be aware that the Mental Capacity Act 2005 requires that any research project involving persons 16 years or over, who lack the capacity to provide informed consent, must seek NHS HRA approval.

ALL applications must complete the following four questions:

Please tickYESNO
1. Does your research involve NHS patients or staff or their issues or materials?
2. Does your research involve NHS data or facilities?
3. Does your research involve social care clients?
4. Does your research involve medical intervention taking place outside of the NHS or overseas?

If you have said ‘Yes’ to any of the above four questions you MUST also complete a NHS research application form and upload it to Canvas with your submission. If you have said ‘No’ to all four questions above, you do not need to complete a NHS research application form.

You can find an application form and assistance with the above by going to: .

Print
Need an custom research paper on New Enterprise Start-up Plan: On-Demand Courier Service to Deli... written from scratch by a professional specifically for you?
808 writers online
Cite This paper
Select a referencing style:

Reference

IvyPanda. (2024, March 7). New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine. https://ivypanda.com/essays/new-enterprise-start-up-plan-on-demand-courier-service-to-deliver-medicine/

Work Cited

"New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine." IvyPanda, 7 Mar. 2024, ivypanda.com/essays/new-enterprise-start-up-plan-on-demand-courier-service-to-deliver-medicine/.

References

IvyPanda. (2024) 'New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine'. 7 March.

References

IvyPanda. 2024. "New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine." March 7, 2024. https://ivypanda.com/essays/new-enterprise-start-up-plan-on-demand-courier-service-to-deliver-medicine/.

1. IvyPanda. "New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine." March 7, 2024. https://ivypanda.com/essays/new-enterprise-start-up-plan-on-demand-courier-service-to-deliver-medicine/.


Bibliography


IvyPanda. "New Enterprise Start-up Plan: On-Demand Courier Service to Deliver Medicine." March 7, 2024. https://ivypanda.com/essays/new-enterprise-start-up-plan-on-demand-courier-service-to-deliver-medicine/.

Powered by CiteTotal, free citation creator
If you are the copyright owner of this paper and no longer wish to have your work published on IvyPanda. Request the removal
More related papers
Cite
Print
1 / 1